BLUESTAR GENOMICS
Bluestar Genomics delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.
BLUESTAR GENOMICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2016-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.bluestargenomics.com
Total Employee:
11+
Status:
Closed
Contact:
(833) 258-7827
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Investors List
Pathology Asia Holdings
Pathology Asia Holdings investment in Series C - Bluestar Genomics
Mattias Westman
Mattias Westman investment in Series C - Bluestar Genomics
Official Site Inspections
http://www.bluestargenomics.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bluestar Genomics"
ClearNote Health | Liquid Biopsy Cancer Detection | Home
We are proud of the clinical evidence, R&D achievements, and our five-year-long company development as Bluestar Genomics. Now, as a commercial-stage company, ClearNote Health …See details»
Bluestar Genomics - VentureRadar
Bluestar Genomics develops next-generation epigenomic approaches to noninvasive molecular testing; providing novel insights in human health and disease towards the improvement of …See details»
Bluestar Genomics Information - RocketReach
Bluestar Genomics is a Biotechnology, Pharmaceuticals, and Healthcare company located in San Diego, California with $2 million in revenue and 47 employees. Find top employees, contact …See details»
www.bluestargenomics.com
Www.bluestargenomics.comSee details»
Bluestar Genomics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Bluestar Genomics, Inc. of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Bluestar Genomics Delivering Precision Epigenomic Medicine
About Bluestar Genomics Delivering Precision Epigenomic Medicine Bluestar Genomics Delivering Precision Epigenomic Medicine is a Biotech related company founded in 2016 and …See details»
Bluestar Genomics Presents Data on New Applications of its …
Sep 12, 2022 Bluestar Genomics is an early cancer detection company focused on the development and commercialization of non-invasive epigenomic tests to detect cancer through …See details»
Bluestar Genomics Appoints David Mullarkey Chief Executive …
“Dave is a terrific addition to the Bluestar Genomics executive team as the company transitions to becoming a commercial organization and brings its non-invasive cancer detection technology …See details»
Bluestar Genomics - Crustdata Company Profile, Funding and …
Bluestar Genomics is a company that delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.See details»
Bluestar Genomics - VentureRadar
"Bluestar Genomics develops next-generation epigenomic approaches to noninvasive molecular testing; providing novel insights in human health and disease towards the improvement of …See details»
Bluestar Genomics - Golden
Bluestar Genomics is a San Francisco-based epigenomic and data approaches for disease and patient information.See details»
Bluestar Genomics Closes $70M Series C Funding, Expands …
May 12, 2021 Bluestar Genomics announces the company has raised $70 million in new equity funding and will be expanding the company's Scientific Advisory Board.See details»
Bluestar Genomics | VentureRadar
Bluestar Genomics develops next-generation epigenomic approaches to noninvasive molecular testing; providing novel insights in human health and disease towards the improvement of …See details»
Bluestar Genomics - Funding, Financials, Valuation & Investors
Bluestar Genomics is a company that delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.See details»
Bluestar Genomics Advances to Commercial Phase ... - ClearNote …
Dec 21, 2022 Company Initiates International Distribution of Its Pancreatic Cancer Detection Test SAN DIEGO – December 21, 2022 – Bluestar Genomics today announced the …See details»
Bluestar Genomics Appoints David Mullarkey Chief Executive Officer
Jan 10, 2022 Bluestar Genomics, Inc. today announced the appointment of David Mullarkey as chief executive officer, effective January 10.See details»
Bluestar Genomics Presents Data on New Applications of its …
About Bluestar Genomics Bluestar Genomics is an early cancer detection company focused on the development and commercialization of non-invasive epigenomic tests to detect cancer …See details»
Bluestar Genomics - GitHub
Bluestar Genomics Popular repositories airbyte Public Forked from airbytehq/airbyte Airbyte is an open-source EL (T) platform that helps you replicate your data in your warehouses, lakes and …See details»
Bluestar Genomics Closes $70M Series C Funding, Expands …
SAN DIEGO, May 12, 2021-- Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today …See details»